
Sign up to save your podcasts
Or


We review the current status of the Ocular Therapeutics TKI sustained release delivery system for treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor of Ophthalmology USC Roski Eye Institute.
By Retina Synthesis4.5
88 ratings
We review the current status of the Ocular Therapeutics TKI sustained release delivery system for treatment of neovascular AMD with Dr. Andrew Moshfeghi, Associate Professor of Ophthalmology USC Roski Eye Institute.

43 Listeners

18 Listeners

99 Listeners

113,168 Listeners

56,921 Listeners

5 Listeners

9,558 Listeners

12 Listeners

47,696 Listeners

51 Listeners

11 Listeners

467 Listeners

19 Listeners

0 Listeners